>PROKKA_00001 Modification methylase DpnIIB
MTDITKSLEDNGFIIKDLIRWEKTNPMPRNRDRRFITDYEVAVWAVKKGGKWTFNRKDES
YERPEVKCGVTPQGEKKLGSHPTQKPIAVMQWIIERLTNENNVVLDPFIGSGTTAIACEN
LHRDYIGFELDNTYYNIANKRIG*
>PROKKA_00002 hypothetical protein
MAYRILHCGESLENYYTCMKEKTIGFTKNIGDKEDIIFLVVKINKAAICGARVIISEKTN
YKPWKDFNKYKICFNITNIEFCKPFQVEILKQVDPEKWGFKFMLGSKEIKEQEAIDLLNS
TFEENKRDSMYIFKEDELRKSKKKKEDNICNDVKQEISSTVQEKDKDNKISNQTNIVPTQ
QNTQLDIMGTFQTINFISEQHEVQGLETLVTKHFYNLFTKYSVDNSILISDNRKFSTATI
KDDNGTTINGISGIPDALLITYNKDDSVPLQISLIEYECYGQQKTSIRQKSDYLNCHIIP
QLMRFASTFSIVTDYKIRENTIKSWVSKISNYIYNDDELTKRTSKWIKELYPDINEMQIA
LRFNEILKQAFENSIKIVLIIDELTNEQKDTIKNIIGAFKLNNNSKNNSIEFASYVVRLE
QKVNIVDDNAQYALSYQE*
>PROKKA_00003 transcriptional regulator BotR, P-21
MNDLFYAIENLKHDNQHFDFIEMSLKKYIEKTSKKYNLYYDYYNDILYHLWKELIEINLK
NFNSELDLRKYISTSIKRYCINICKKKNRDKKIIYNSEATYKKLEAVNVYSLYCEDFEFL
DLISILNYKEKQIIYMKFFECRKDNEIARRLHLSRQFIYKIRIKSLKKLYPIVMQLVNI*
>PROKKA_00004 Hemagglutinin components HA-22/23/53 precursor
MSLSIKELYYTKDKSINNVNLADGNYVVNRGDGWILSRQNQNLGGNISNNGCTAIVGDLR
IRETATPYYYPTASFNEEYIRNNVQNVFANFTEASEIPIGFEFSKTAPSNKGLYMYLQYT
YIRYEIIKVLRNTVIERAVLYVPSLGYAKSIEFNSGEQIDKNFYFTSEDKCILNEKFIYK
KIAETTTAKESNDSNNTTNLNTSQTILPYPNGLYVINKGDGYMRTNDKDLIGTLLIETNT
SGSIIQPRLRNTTRPLFNTSNPTLFSQEYTEARLNDAFNIQLFNTSTTLFKFVEEAPDNK
NISMKAYNTYEKYELINYQNGNIADKAEYYLPSLGKCEVSDAPSPQAPVVETPVEQDGFI
QTGPNENIIVGVINPSENIEEISTPIPDDYTYNIPTSIQNNACYVLFTVNTTGVYKINAQ
NNLPPLIIYESIGSDNMNIQSNTLSNNNIKAINYITGTDSSNAESYLIVSLIKNKNYYIR
IPQISSSTTNQLIFKRELGNISDLANSTVNILDNLNTSGTHYYTRQSPDVGNYISYQLTI
PGDFNNIASSIFSFRTRNNQGIGTLYRLTESINGYNLITIKNYSDLLNNVEPISLLNGAT
YIFRVKVTELNNYNIIFDAYRNS*
>PROKKA_00005 HA 17 kDa subunit
MSSERTFLPNGNYKIKSLFSDSLYLTYSSGSLSFLNTSSLDNQKWKLEYISSSNGFRFSN
VAEPNKYLAYNDYGFIYLSSSSNNSLWNPIKIAINSYIICTLSIVNVTDYAWTIYDNNNN
ITDQPILNLPNFDINNSNQILKLEKL*
>PROKKA_00006 hypothetical protein
MSQTNANDLRNNEVFFISPSNSTNKVLDKISQSEVKLWSKNLGSNQKWRLIYDTNKQAYK
IKVMDNTSLILTWDAPLSSVSVKTDTNTNNQYWYLLQDYISRNVILRNYMNPNLVLQYNT
DDTLIVSTQTNSNNQFFKFSNCIYEALNNRNCKLQTQLNSDRFLSKNLNSQIIVLWQWFD
SSRQKWTIEYNETKSAYTLKCQENNRYLTWIQNSNNYVETYQSTDSLIQYWNINYLDNDA
SKYILYNLQDTNRVLDVYNSQTANGTHVIVDSYHGNTNQQWIINLI*
>PROKKA_00007 Botulinum neurotoxin type E precursor
MDINDDLNINSPVDNKNVVIVRARKTNTFFKAFKVAPNIWVAPERYYGEPLDIAEEYKLD
GGIYDSNFLSQDSERENFLQAIITLLKRINNTISGKQLLSLISTAIPFPYGYVGGGYSSP
NIFTFGKTPKSNKKLNSLVTSTIPFPFGGYRETNYIESQNNKNFYASNIVIFGPGSNIVE
NNVICYKKNDAENGMGTMAEILFQPLLTYKYNKFYIDPAMELTKCLIKSLYFLYGIKPSD
DLVVPYRLRTELDNKQFSQLNIIDLLISGGVDLEFINTNPYWFTNSYFSNSIKMFEKYKN
IYETEIEGNNAIGNDIKLRLKQKFQNSVQDIWNLNLNYFSKEFNSIIPDRFSNALKHFYR
KQYYTMDYGDNYNINGFVNGQINTKLPLSDKNTNIISKPEKVVNLVNANNISLMKSNIYG
DGLKGTTEDFYSTYKIPYNEEYEYRFNDSDNFPLNNISIEEVDSIPEIIDINPYKDNSDD
LLFTQITSTTEEVITHTALPVNYLQAQIITNENFTLSSDFSKVVSSKDKSLVYSFLDNLM
SYLETIKNDGPIDTDKKYYLWLKEVFKNYSFDINLTQEIDSSCGINEVVIWFGKALNILN
TSNSFVEEYQNSGPISLISKKDNLSEPNIEIDDIPDSLLGLSFKDLNNKLYEIYSKNRVY
FRKIYFNFLDQWWTEYYSQYFELICMAKQSILAQESVVKQIIQNKFTDLSKASIPPDTLK
LIKETTEKTFIDLSNESQISMNRVDNFLNKASICVFVEDIYPKFISYMEKYINNINIKTR
EFIQRCTNINDNEKSILINSYTFKTIDFKFLNIQAIKNFFNSQVEQVMKEMLSPYQLLLF
ATRGPNSNIIEDISGKNTLIQYTESVELVYGVNGESLYLKSPNETVEFSNNFFTNGLTNN
FTICFWLRFTGKDDDKTRLIGNKVNNCGWEIYFEDNGLVFEIIDSNGNQESVYLSNVINN
NWYYISISVDRLKDQLLIFINDKNVANVSIEQILNIYSTNVISLVNKNNSIYVEELSVLD
KPVASEEVIRNYFSYLDNSYIRDSSKSLLEYNKNYQLYNYVFPETSLYEVNDNNKSYLSL
KNTDGINIPSVKFKLINIDESKGYVQKWDECIICVSDGTEKYLDISPENNRIQLVSSKDN
AKKITVNTDLFRPDCITFSYNDKYFSLSLRDGDYNWMICNDNNKVPKGAHLWILKS*
>PROKKA_00008 Botulinum neurotoxin type D precursor
VDIKKLGDVNIMTWPVKDFNYSDPVNDNDILYLRIPQNKLITTPVKAFMITQNIWVIPER
FSSDTNPSLSKPPRPTSKYQSYYDPSYLSTDEQKDTFLKGIIKLFKRINERDIGKKLINY
LVVGSPFMGDSSTPEDTFDFTRHTTNIAVEKFENGSWKVTNIITPSVLIFGPLPNILDYT
ASLTLQGQQSNPSFEGFGTLSILKVAPEFLLTFSDVTSNQSSAVLGKSIFCMDPVIALMH
ELTHSLHQLYGINIPSDKRIRPQVSEGFFSQDGPNVQFEELYTFGGSDVEIIPQIERLQL
REKALGHYKDIAKRLNNINKTIPSSWSSNIDKYKKIFSEKYNFDKDNTGNFVVNIDKFNS
LYSDLTNVMSEVVYSSQYNVKNRTHYFSKHYLPVFANILDDNIYTIINGFNLTTKGFNIE
NSGQNIERNPALQKLSSESVVDLFTKVCLRLTRNSRDDSTCIQVKNNTLPYVADKDSISQ
EIFESQIITDETNVENYSDNFSLDESILDAKVPTNPEAVDPLLPNVNMEPLNVPGEEEVF
YDDITKDVDYLNSYYYLEAQKLSNNVENITLTTSVEEALGYSNKIYTFLPSLAEKVNKGV
QAGLFLNWANEVVEDFTTNIMKKDTLDKISDVSAIIPYIGPALNIGNSALRGNFKQAFAT
AGVAFLLEGFPEFTIPALGVFTFYSSIQEREKIIKTIENCLEQRVKRWKDSYQWMVSNWL
SRITTQFNHISYQMYDSLSYQADAIKAKIDLEYKKYSGSDKENIKSQVENLKNSLDVKIS
EAMNNINKFIRECSVTYLFKNMLPKVIDELNKFDLKTKTELINLIDSHNIILVGEVDRLK
AKVNESFENTIPFNIFSYTNNSLLKDMINEYFNSINDSKILSLQNKKNTLMDTSGYNAEV
RVEGNVQLNPIFPFDFKLGSSGDDRGKVIVTQNENIVYNAMYESFSISFWIRINKWVSNL
PGYTIIDSVKNNSGWSIGIISNFLVFTLKQNENSEQDINFSYDISKNAAGYNKWFFVTIT
TNMMGNMMIYINGKLIDTIKVKELTGINFSKTITFQMNKIPNTGLITSDSDNINMWIRDF
YIFAKELDDKDINILFNSLQYTNVVKDYWGNDLRYDKEYYMINVNYMNRYMSKKGNGIVF
NTRKNNNDFNEGYKIIIKRIIGNTNDTRVRGENVLYFNTTIDNKQYSLGMYKPSRNLGTD
LVPLGALDQPMDEIRKYGSFIIQPCNTFDYYASQLFLSSNATTNRIGILSIGSYSFKLGD
DYWFNHEYLIPVIKIEHYASLLESTSTHWVFVPASE*
>PROKKA_00009 hypothetical protein
VVEEQRLNKDLQKVKEKFIRALVKTLNEENENREYENKEPLDVCFMVSAIDKQLYQYKDF
IEDLSNGYTFNMYEEDESGHSNGRISLFIEKPKEERQSGLWIEKYREDYWYTIEFKYNQI
DGDYCQCEQGNEGYNEEHHCCGEICDWNAPSFAITKQYDLGTCSWDGLQRDYWEYEKMFK
SKEENKSVEDEIKERRKQEIMEQINLLNQELISLES*
>PROKKA_00010 PQ loop repeat
MSKQVISFLLQLSGSILLLGGYFPQIIQLYKTKKSEDISLSFWVILTTGLFCIAFNMLIS
HVPNFIMVTQFLNAIIALWVLVLVKKYK*
>PROKKA_00011 Nucleoside 2-deoxyribosyltransferase
MKNINIESTTTEQKQGYIAGGLFNEADISQRLKEGRLLRENTNIDFYNPIEAPCNDKSKL
PTDQDIFNIDAQKVLQSHTVIADISTRDEGVMAELGIAWTCNFIHHLAEQGYTLEDILKY
IPKKEIYANLPDIRKGTAHNYKGNYIPVGFNQFIIGMIRQMGDVYDGFNDILKDLKKDNK
*
>PROKKA_00012 Thymidine kinase
MAQLYYRYGVLNSAKSANLIMAVHNYDKKNRRVVVLKPKIDTRSKPNIVESRVGISHACI
DFDKNENLFELVNTLNSKDTIYAVFIEEVQFITKEQAKQLHNIVHELNIPTLGYGLKNTY
IDGELFEGSKAMLFYADKIEEIKDVCEYCNKKATQNLRVVNGEPIYRGETIRIGDVNSNV
EEYYVPVCGYHYYHPELK*
>PROKKA_00013 hypothetical protein
MILEFNGYKIVTDDKQFIVQKKKVVQAGRLTKEENIGKEYWEDVGYFTNLNFALKFIKKT
ILLDNDDLKVIMDRLNQLEGKIDEFTQKLGE*
>PROKKA_00014 hypothetical protein
MSLLSIHKAQENMKDSATKWLEMKESCKYRALDYGTEGKLKMTITELIDKLNSIYIFHED
LEVDIQDKEITF*
>PROKKA_00015 hypothetical protein
MKVRDLRNELELLDGELEIAIVDDENFDYDLGKIYLNPNFYGEMRLILTATNE*
>PROKKA_00016 putative zinc finger/helix-turn-helix protein, YgiT family
MQENIAFCPKCKRKVQYRIRKNIIEEYKGVKVNVKENIGVCSQCNEDIFVTELETDNLKR
LYQKYEEITGIKIKSKLANP*
>PROKKA_00017 putative NHN endonuclease
MKINNFNVDLYKGKGYQCNIGDTVNIDIKDVSAHSKNKIKIQCDKCKTNIKEITIASLHH
SKSYQEGNYICYECKEKILPQMKCEVCGSTHKVTNYLNEGNLLCQRHQRILRKKGDIKRT
IYDPNEIHIYEDYAEFDTYDINGDINGIFKIDLDVVNFVKSHKIYKHKDGYACYKFKDKN
NKTKNMRLHRYIMNVHNAKDKSIIVDHINRDKQDNRRHNLRLATFKDNVVNTGMFSTNTS
GHKGISWNKQRKTWEVYIHQYNKKIGLGYYKDYDKAVKVREIAEIIYFGSNNPEYNKLIK
KYIDNPKIQHILLNHREEYIND*
>PROKKA_00018 DNA topoisomerase 4 subunit B
MTKQKVINYYDDRGKVRNKIGIWLGSNTHQAVIHTIKELTANSGDILIENIGSKIIWTIY
DDKTVEIYDDGTGLPLEGTTIIKKKDVKGRETTEVKSNYELLLLTLFAGTKHNGLETGEK
NTGSNGVFNTVLTYSSEYVEYEIGRPDGNIYFCSFKEGFIDKELQIIGKTDKTYTRIKYK
LSDQVYTENKFTFDEICDICQKQSALIKKPIIIVDETTNQEVTYNLSNGLEELFNVYLHD
KSKSCKDIIIKDSFSQDVTFENHQYKDNMNYELILNYTIEENNNVNMDFLNRSELIHHGT
IQDGIIDGLRKCIHNFINKEGLYNKKESNISKDDILCGLNYMIDFSSLHPNMYSNQTKFE
TKVKYFKTHLTKSIMDYFEIYAIEHKDEMLKIANKLLINKRSREKAEVNRKEIRKKLEQD
VNKSTGRPDKFVPCQSKNKHEKELILIEGDSSLNSVKLSRNKKVHSIYPLKGKPLNTLKK
SLDDILKNEEVTDIFQILQCGMQYKGKSIKGVKQFNIDDLDVDKIIIFSDEDEDGLHIRS
LVIGIFYVLAPKIIAQGHLYVLDSPLYRIDTKNKTYLAYNEKEKNNIIKNLNNQNEKFTD
SRFKGLGGLSVDLLSETAMNIENRKLTQITINDIEKAKQVLEMFMDDDSTDRKQYIEKFG
EQYFDYSIYEI*
>PROKKA_00019 DNA gyrase subunit A
MIIQSEVSEAIREYYMPYAMKVITDRALPDVRDGLKPIARRILWTMWNNGLLHNKPRAKC
GKVVGDILKIHNHGDSSVYNALSLLTDQNESLLQGFIDGEGAFGKIYSKDSPSAMRYTSA
RLNKFSQEMFKNIDKDIVKFIGEDKEHLQPLCLPNTFPNILIKPNSGVAVGEACNWCSFN
LVEVCNLTQEYIKNNNINVIDYLTAPDFSTGGYIITSNFDLNKIYETGRGSFRLQAKYKY
NEKENTIEVYEIPYNTTVEDIKKEITNLMKSDRLKEVKDVKDGTGYNTKLKKEEMGVIIE
IKNNVNPNRLMKKLFKYTSLNKSFNCNFNCLVNYRPQVLGIKQILNEWLKFRIECVKESI
KYDLNNKIKLLHFLKGLEKVLLNIDKAVEIIRYSKTDSLIINNLRKEFNIDEQQANDIAN
MKLKNINEQYINNKVQSILEIQKEHDKLKGLLQSEKDIQNIIIDELEKVKNNYGKARKTE
LLNKHEIEDTSHEDLVEDFNPTIVLTEQQYIKKNRVFSQSQKLKDDDKILQFHQCNNKDD
LLLFTNKGNVLIRKVYELDEHKPSTYGDFLPNLLGEHLENDEKVIYISTTKDYKGSVISV
FENGYIARTDLHTYKPKQNRQIPMSAYNTESKIVSIQLITNDTDIFLVSQEGKALIINTS
QIRPTKSRNTQGISGMKIDTQTNKIIASIIGVTVDDNFNIETEKGKSKFIMLNDIAPNGK
ESMTEYLKGNRNTQGNFIYNTRQKNDKVIKIIKQES*
